Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amira A Barkal

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Plos One|April 1, 2016
Cas9 Functionally Opens ChromatinAmira A Barkal, Sharanya Srinivasan, Tatsunori Hashimoto, et al.
Scientific Data|December 21, 2016
An atlas of transcriptional, chromatin accessibility, and surface marker changes in human mesoderm developmentPang Wei Koh, Rahul Sinha, Amira A Barkal, et al.
Nature Biotechnology|January 21, 2014
Discovery of directional and nondirectional pioneer transcription factors by modeling DNase profile magnitude and shapeRichard I Sherwood, Tatsunori Hashimoto, Charles W O'Donnell, et al.
Genome Research|July 27, 2016
A synergistic DNA logic predicts genome-wide chromatin accessibilityTatsunori Hashimoto, Richard I Sherwood, Daniel D Kang, et al.
Nature|August 2, 2019
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapyAmira A Barkal, Rachel E Brewer, Maxim Markovic, et al.
Nature Cancer|November 21, 2022
Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effectYoko Nishiga, Alexandros P Drainas, Maya Baron, et al.
Nature|September 9, 2021
Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosisRoarke A Kamber, Yoko Nishiga, Bhek Morton, et al.
Nature Immunology|November 29, 2017
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapyAmira A Barkal, Kipp Weiskopf, Kevin S Kao, et al.
Cell|July 16, 2016
Mapping the Pairwise Choices Leading from Pluripotency to Human Bone, Heart, and Other Mesoderm Cell TypesKyle M Loh, Angela Chen, Pang Wei Koh, et al.
Nature Genetics|November 7, 2018
Identification of phagocytosis regulators using magnetic genome-wide CRISPR screensMichael S Haney, Christopher J Bohlen, David W Morgens, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|April 1, 2016
Cas9 Functionally Opens ChromatinAmira A Barkal, Sharanya Srinivasan, Tatsunori Hashimoto, et al.
Scientific Data|December 21, 2016
An atlas of transcriptional, chromatin accessibility, and surface marker changes in human mesoderm developmentPang Wei Koh, Rahul Sinha, Amira A Barkal, et al.
Nature Biotechnology|January 21, 2014
Discovery of directional and nondirectional pioneer transcription factors by modeling DNase profile magnitude and shapeRichard I Sherwood, Tatsunori Hashimoto, Charles W O'Donnell, et al.
Genome Research|July 27, 2016
A synergistic DNA logic predicts genome-wide chromatin accessibilityTatsunori Hashimoto, Richard I Sherwood, Daniel D Kang, et al.
Nature|August 2, 2019
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapyAmira A Barkal, Rachel E Brewer, Maxim Markovic, et al.
Nature Cancer|November 21, 2022
Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effectYoko Nishiga, Alexandros P Drainas, Maya Baron, et al.
Nature|September 9, 2021
Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosisRoarke A Kamber, Yoko Nishiga, Bhek Morton, et al.
Nature Immunology|November 29, 2017
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapyAmira A Barkal, Kipp Weiskopf, Kevin S Kao, et al.
Cell|July 16, 2016
Mapping the Pairwise Choices Leading from Pluripotency to Human Bone, Heart, and Other Mesoderm Cell TypesKyle M Loh, Angela Chen, Pang Wei Koh, et al.
Nature Genetics|November 7, 2018
Identification of phagocytosis regulators using magnetic genome-wide CRISPR screensMichael S Haney, Christopher J Bohlen, David W Morgens, et al.
Pageof 1